anyone hearing?

Quote
Just because you are a legacy rep does not mean you are successful. Concentrate on growing your own pathetic territories. Sharing useless information is not fooling anyone when you have never proven yourself to be successful.
 






anonymous said:
Just because you are a legacy rep does not mean you are successful. Concentrate on growing your own pathetic territories. Sharing useless information is not fooling anyone when you have never proven yourself to be successful.
Click to expand...
Thanks Tiger! In the words of Trump, "Folks, something is really, really wrong".
 










































no more programs, no samples and a bunch of us just joined here and on plans. who calls the shots around this place? What are these people smoking besides each other's Bologna?
 






Mr. Jermasek and Mr. Chambers each bring extensive experience in the pharmaceutical industry, including expertise in building successful, results-oriented commercial organizations.

WHEN IS THIS GOING TO HAPPEN?
 






shit can any territory <100 scripts/quarter, any rep here since last year <150/quarter needs to leave, boot the dms and reps who are just twiddling their thumbs, making excuses, and whining. stop with "it takes time" it's called accountability, shit or get off the pot! stop paying for underperformance bernie

anonymous said:
no more programs, no samples and a bunch of us just joined here and on plans. who calls the shots around this place? What are these people smoking besides each other's Bologna?
Click to expand...
 












Mr. Madison continued, “Since joining Keryx, Tony efficiently and effectively executed our field force expansion and has implemented programs for our field-based teams that are driving adoption of Auryxia. He joined Keryx at a critical time in the launch of this medicine. His pragmatism, coupled with a sense of urgency and results-driven approach have contributed significantly to the turnaround of Auryxia. The complementary backgrounds and expertise of Doug and Tony are a great asset for Keryx.”

Masturbatory quotes like this make you wonder.
 


















Has the average weekly scripts per rep even gone up under TC? GM cites a "turnaround", but it just seems as though anyone with a pulse is getting hired. Sure absolute numbers are rising, but at a significant cost.
 






anonymous said:
Mr. Madison continued, “Since joining Keryx, Tony efficiently and effectively executed our field force expansion and has implemented programs for our field-based teams that are driving adoption of Auryxia. He joined Keryx at a critical time in the launch of this medicine. His pragmatism, coupled with a sense of urgency and results-driven approach have contributed significantly to the turnaround of Auryxia. The complementary backgrounds and expertise of Doug and Tony are a great asset for Keryx.”

Masturbatory quotes like this make you wonder.
Click to expand...
 






anonymous said:
Mr. Madison continued, “Since joining Keryx, Tony efficiently and effectively executed our field force expansion and has implemented programs for our field-based teams that are driving adoption of Auryxia. He joined Keryx at a critical time in the launch of this medicine. His pragmatism, coupled with a sense of urgency and results-driven approach have contributed significantly to the turnaround of Auryxia. The complementary backgrounds and expertise of Doug and Tony are a great asset for Keryx.”

Masturbatory quotes like this make you wonder.
Click to expand...
 






Hmmm. If anyone understands the meaning of pragmatism it means thinking about situations that are sensible and realistic not theoretical. Realistically there is absolutely no sense to the madness. Theoretically Auryxia may take off in a few years but other products are making it to the market first for iron in the dialysis setting. Do your homework people. Auryxia is a late market binder with poor coverage. Iron. That will be late to market too.
 






anonymous said:
Hmmm. If anyone understands the meaning of pragmatism it means thinking about situations that are sensible and realistic not theoretical. Realistically there is absolutely no sense to the madness. Theoretically Auryxia may take off in a few years but other products are making it to the market first for iron in the dialysis setting. Do your homework people. Auryxia is a late market binder with poor coverage. Iron. That will be late to market too.
Click to expand...
And sales force morale?
 






Top Bottom
Back
Quote